CST3 and neoplasm: CRISPR‐based knockout of CST3 or SNCG in HCT116 significantly suppressed the colony formation capacities, elevated tumor sensitivity to irradiation and inhibited the subcutaneous tumorigenicity in vivo (Figure 6G,H; Figure S5G, Supporting Information).